Clinical Trial Update: Ferumoxytol-enhanced Magnetic Resonance Imaging [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ferumoxytol-enhanced MRI for coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Transmed Solutions | Conditions: Coronary Artery Disease | Phase 3 | Status: TERMINATED